Key facts
- This page summarizes Vicki L. Goodman's Form 4 filing for EXELIXIS, INC. (EXEL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Apr 2023, 20:24.
Vicki L. Goodman - 03 Apr 2023 Form 4 Insider Report for EXELIXIS, INC. (EXEL)
- Reporting relationship
- EVP, Prod Dev & Med Aff &CMO
- Issuer ticker
- EXEL
- Reported as of
- 03 Apr 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Apr 2023, 20:24:18 UTC
- Prior SEC filing
- 17 Feb 2023
- Next SEC filing
- 15 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nina Ayer, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Vicki L. Goodman filed Form 4 for EXELIXIS, INC. (EXEL) on 05 Apr 2023.
Change
- Previous filing in this sequence was filed on 17 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXEL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +82,566
- Change %
- +37%
- Price
- $0.000000
- Shares after
- 307,654
- Date
- 03 Apr 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.
Footnote F2
The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2024 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested.
Footnote F3
Includes 246,383 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.